Literature DB >> 32104511

Erratum: Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes: Erratum.

Jinghan Su1,2, Huiping Sun1,3, Qingshuo Meng1,2, Pengcheng Zhang1, Qi Yin1, Yaping Li1,2.   

Abstract

[This corrects the article DOI: 10.7150/thno.17259.]. © The author(s).

Entities:  

Year:  2020        PMID: 32104511      PMCID: PMC7019168          DOI: 10.7150/thno.42848

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


In the initially published version of this article, the “Heart” image of the RMSNs+Laser group in Figure 7 is wrong. The correct Figure 7 is as follow:
Figure 7

H&E staining of heart, liver, spleen and kidney (100×) at the end of the antitumor inhibition test. The black circles indicated the inflammation in the heart of the Dox-treated mice. Scale bar = 100 μm.

The corrections made in this erratum do not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that this error may have caused.
  1 in total

1.  RGD Peptide Modified Erythrocyte Membrane/Porous Nanoparticles Loading Mir-137 for NIR-Stimulated Theranostics of Glioblastomas.

Authors:  Minghui Li; Xinyu Cui; Feng Wei; Chao Li; Xiaojun Han
Journal:  Nanomaterials (Basel)       Date:  2022-04-26       Impact factor: 5.719

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.